SlideShare a Scribd company logo
Pharmacokinetic parameters
Presented by-
Deepak Pandey
Outline
• Enumeration and brief overview of different pharmacokinetic
parameters-
• Absorption-
• Bioavailability
• Distribution-
• Volume of distribution
• Metabolism and Excretion-
• Clearance
• Half life and order of elimination
• Elimination constant
• Dosing regimens
• Therapeutic drug monitoring
Concentration time graph
• Peak plasma concentration
• Time of peak plasma
concentration
• Area under the curve
• Minimum effective
concentration
• Maximum safe
concentration
• Onset of action
• Time of onset
• Duration of action
• Intensity of action
• Therapeutic range
• Therapeutic index
Maximum
Bioavailability (F)
• Fraction of administered drug which
reaches systemic circulation in unchanged
form
• It is expressed as fraction or percentage and
can range between 0 and 1
• In a concentration time graph, the area
under curve (AUC) represents the total dose
of drug in plasma
• Thus, bioavailability can be calculated as-
Bioavailability
• Factors affecting bioavailability of a drug include-
• Particle size
• Degree of ionization and pH at the site of absorption
• Gastric emptying & GI motility (TCA and anti histamines)
• Food and other substances (Grapefruit juice and felodipine)
• First pass metabolism (Sublingual vs Oral)
• Drug interactions (Tetracyclines forming complexes with iron and antacids
in gut lumen, bisphosphonates with calcium)
• Route of administration
• Area and perfusion of site of drug administration (Muscle vs Fat)
Distribution of drug
• One compartment model-
• Few drugs (Aminoglycosides) are
rapidly distributed in tissues and
aren’t significantly accumulated in
tissues such that the entire body
works like a single compartment.
• Their plasma concentration will
decrease mostly due to clearance or
metabolism and thus they will show
continuous logarithmic decline in
concentration time graph.
Distribution of drug
• Two compartment model-
• Few drugs are slowly absorbed into
peripheral tissues like Vancomycin
and Digoxin.
• Their plasma concentration graph will
show two slopes of decline which are
of redistribution and elimination.
Distribution of drug
• Factors determining rate of distribution and amount of drug
distributed to different body tissues-
• Regional blood flow to the tissue
• Capillary permeability
• Volume of tissue and tissue selectivity of drug (Incorporation of
Bisphosphonates into bone)
• Extent of plasma protein binding of drug as only the unbound fraction is
available for transport into tissues
• Presence of barriers (Blood brain barrier)
Volume of distribution (Vd)
• It is an apparent volume available for
administered amount of drug to
disperse considering the whole human
body as a homogenous solution
• Volume of distribution = Quantity of
drug administered/ Plasma
concentration (C)
• It shows the extent of redistribution or
accumulation of drug in tissues
• Eg- Warfarin has low (Vd) owing to its
high plasma protein binding while
Chloroquine has high (Vd) because of
its accumulation into peripheral fat.
Volume of distribution
• It is used to determine the loading dose of a drug
• Loading dose = Target concentration X Volume of distribution
Suppose the target concentration of a drug is 15mg/ml and Volume of
distribution of the same drug is 30 L.
• Since, the Volume of distribution of a drug in a patient doesn’t depend on the
amount of drug administered or the route of administration, it will remain
same
Then, the loading dose will be 15mg/ml X 30L = 1.5g/L X 30L i.e, 45 g
Volume of distribution
• Factors affecting volume of distribution
• Lipid solubility of the drug
• Ionization of the drug at physiological pH
• Plasma protein binding of the drug
• Limitation- It is assumed that the concentration of drug in different
tissues corresponds to the plasma concentration and that the
response of drug varies in accordance with the plasma concentration
which may not be true in each case.
Kinetics of drug elimination
• First order kinetics (A) - The rate
of drug elimination varies
proportionately to the plasma
concentration of drug. Most of
the drugs follow this pattern of
elimination.
• Here, as plasma concentration of
drug decrease, the rate of drug
elimination decreases and vice
versa. (Rate of drug elimination is
the amount of drug removed
from blood per unit time)
Kinetics of drug elimination
• Saturation kinetics (B) - The rate of drug
elimination becomes constant after a
certain level of plasma concentration is
reached i.e., A fixed amount of drug will
be removed from blood in unit time. The
drugs include Phenytoin, Ethanol,
Salicylates
• For few drugs(C), (Valproate and
Disopyramide), as the plasma
concentration increases, the plasma
protein gets saturated and the
concentration of unbound drug increases
leading to disproportionately increased
elimination of drug
Clearance
• Volume of plasma that contains the amount of drug that is removed
from body per unit time
• Suppose, the rate of elimination of drug is 10mg/min and plasma
concentration of drug is 5mg/ml. Then,
Clearance = 10 mg/min/5mg/ml = 2ml/min i.e, 2ml of plasma is cleared of drug
every minute
• It remains constant for drugs showing first order metabolism
• The clearance of a drug include-
• Hepatic clearance
• Renal clearance
• Others
Clearance
• Factors affecting clearance of a drug include-
• Extraction ratio of organ (liver, kidney)- The
fraction of drug removed from plasma flowing
through the organ per unit of time. i.e., If a drug
X has a concentration of 15mg/ml in portal vein
(CA) and concentration of 10mg/ml in hepatic
vein (CV). Then, hepatic extraction ratio will be-
CA - CV/ CA = 5/15 = 1/3
• Plasma protein binding of drug
• Blood flow to the organ (liver, kidney)
• Functional state of kidney, liver
• Interactions with other drugs (enzyme
inducers/inhibitors)
Steady-state concentration
• When the drug is administered at a
constant rate or at regular intervals, the
cumulative accumulation of drug and
simultaneous elimination are balanced
and a steady concentration is reached
• For maintenance of steady state
concentration, the vol of drug that is
cleared of drug must be replenished
continuously. Thus, clearance is used for
calculating maintenance dose as under-
where, Cp is the plasma concentration of
drug, CL is clearance and F is bioavailability
of drug
Elimination rate constant (Ke)
• Fraction of drug that is excreted from the body per unit time
• Rate of elimination = Ke X Concentration of drug in plasma
• Thus, Ke = Clearance/Volume of distribution
• The relationship between concentration at a time t (C) after
administering the drug and the steady state concentration (Css) of the
drug is derived as-
• Thus, we can calculate plasma concentration at a time t by knowing
the elimination rate constant and steady state concentration of the
drug
Half life (t1/2)
• Half life of a drug is the time taken for its plasma concentration to
drop to half of the peak plasma concentration
• Half life of a drug determines
• Duration of action of drug after a single dose
• Time required to reach steady state concentration
• Dosing frequency
• For a drug following first order kinetics, the half life can be derived as-
i.e, the half life depends on both volume of distribution and clearance of the
drug
Dosage regimens
• Ideal dosage regimen- Dosing intervals and amount of drug given in each dose is such that the
plasma concentration of drug stays above the minimum effective concentration within the
therapeutic window
• The dosage regimen for different drugs is arrived through different ways-
• For drugs where physical parameters can be assessed (BP, Blood glucose), a trial and error
method is used where the dose and intervals are titrated accordingly
• Few drugs have wide range of therapeutic window (Penicillins) where maximum efficacy is
desired
• The change in plasma concentration (ΔC) after a single oral dose-
• Thus, the loading dose becomes-
• For maintenance dose-
(where T is the dosing interval)
Therapeutic drug monitoring
• Purpose- To adjust plasma concentration and maintain it within a specified
range.
• Measurement of both values of minimum and maximum concentrations
are to be recorded.
• The necessary dose adjustment is done considering the clearance of drug
to remain constant.
• Applied when-
• The drug has a low therapeutic index
• There is a good plasma concentration- biological response relationship
• There are no other easily measurable physiological parameters
• Or, to monitor adherence or adverse drug reactions
Therapeutic drug monitoring
• Sampling of blood is to be done
only after steady state of plasma
concentration is reached, ie, after
five half lives except in case of
toxicity
• After the steady state is reached,
sampling to be done after proper
time for distribution of drug to
finish.
• A therapeutic range of plasma
concentration is used to guide the
desired concentration of drug
THANK YOU

More Related Content

What's hot

Causes of Non linear pharmacokinetics
Causes of Non linear pharmacokineticsCauses of Non linear pharmacokinetics
Causes of Non linear pharmacokinetics
Snehal Patel
 
One compartment model IV Infusion
One compartment model IV InfusionOne compartment model IV Infusion
One compartment model IV Infusion
LakshmiChandran20
 
Concept of clearance & factors affecting renal excretion
Concept of clearance & factors affecting renal excretionConcept of clearance & factors affecting renal excretion
Concept of clearance & factors affecting renal excretion
chiranjibi68
 
Kinetics of multiple dosing
Kinetics of multiple dosingKinetics of multiple dosing
Kinetics of multiple dosing
PreetiPatilVibhute
 
pH partition theory of drug absorption
pH partition theory of drug absorptionpH partition theory of drug absorption
pH partition theory of drug absorption
Aravinda Palyam
 
Biopharmaceutics: Mechanisms of Drug Absorption
Biopharmaceutics: Mechanisms of Drug AbsorptionBiopharmaceutics: Mechanisms of Drug Absorption
Biopharmaceutics: Mechanisms of Drug Absorption
SURYAKANTVERMA2
 
METHOD OF RESIDUALS
METHOD OF RESIDUALSMETHOD OF RESIDUALS
METHOD OF RESIDUALS
Divya Pushp
 
Factors affecting distribution of drug
Factors affecting distribution of drugFactors affecting distribution of drug
Factors affecting distribution of drug
Dr. SHUBHRAJIT MANTRY
 
Factors affecting drug absorption
Factors affecting drug absorptionFactors affecting drug absorption
Factors affecting drug absorption
SURYAKANTVERMA2
 
Protein binding of drug.ppt
Protein binding of drug.pptProtein binding of drug.ppt
Protein binding of drug.ppt
ramchoure90
 
Two compartment model iv bolus muju
Two compartment model iv bolus mujuTwo compartment model iv bolus muju
Two compartment model iv bolus muju
Hirepravin
 
Absorption of drugs from non per os extravascular administration
Absorption of drugs from non per os extravascular administrationAbsorption of drugs from non per os extravascular administration
Absorption of drugs from non per os extravascular administration
Suvarta Maru
 
MECHANISMS OF DRUG ABSORPTION
MECHANISMS OF DRUG  ABSORPTIONMECHANISMS OF DRUG  ABSORPTION
MECHANISMS OF DRUG ABSORPTION
Dr. SHUBHRAJIT MANTRY
 
Distribution of drugs
Distribution of drugsDistribution of drugs
Distribution of drugs
Faizan Ahmed Mohammed Israeel
 
Drug distribution
Drug distributionDrug distribution
Drug distribution
Dr.K.Umasankar Krishnamaraju
 
Non linear pharmacokinetics and different volumes of distribution
Non linear pharmacokinetics and different volumes of distributionNon linear pharmacokinetics and different volumes of distribution
Non linear pharmacokinetics and different volumes of distributionMalla Reddy College of Pharmacy
 
Theories of Dissolution
Theories of DissolutionTheories of Dissolution
Theories of Dissolution
PRASHANT DEORE
 

What's hot (20)

Causes of Non linear pharmacokinetics
Causes of Non linear pharmacokineticsCauses of Non linear pharmacokinetics
Causes of Non linear pharmacokinetics
 
One compartment model IV Infusion
One compartment model IV InfusionOne compartment model IV Infusion
One compartment model IV Infusion
 
Concept of clearance & factors affecting renal excretion
Concept of clearance & factors affecting renal excretionConcept of clearance & factors affecting renal excretion
Concept of clearance & factors affecting renal excretion
 
Kinetics of multiple dosing
Kinetics of multiple dosingKinetics of multiple dosing
Kinetics of multiple dosing
 
pH partition theory of drug absorption
pH partition theory of drug absorptionpH partition theory of drug absorption
pH partition theory of drug absorption
 
Biopharmaceutics: Mechanisms of Drug Absorption
Biopharmaceutics: Mechanisms of Drug AbsorptionBiopharmaceutics: Mechanisms of Drug Absorption
Biopharmaceutics: Mechanisms of Drug Absorption
 
Pharmacokinetic models
Pharmacokinetic modelsPharmacokinetic models
Pharmacokinetic models
 
Non linear pharmacokinetics
Non linear pharmacokineticsNon linear pharmacokinetics
Non linear pharmacokinetics
 
METHOD OF RESIDUALS
METHOD OF RESIDUALSMETHOD OF RESIDUALS
METHOD OF RESIDUALS
 
Factors affecting distribution of drug
Factors affecting distribution of drugFactors affecting distribution of drug
Factors affecting distribution of drug
 
Factors affecting drug absorption
Factors affecting drug absorptionFactors affecting drug absorption
Factors affecting drug absorption
 
Multicompartment Models
Multicompartment ModelsMulticompartment Models
Multicompartment Models
 
Protein binding of drug.ppt
Protein binding of drug.pptProtein binding of drug.ppt
Protein binding of drug.ppt
 
Two compartment model iv bolus muju
Two compartment model iv bolus mujuTwo compartment model iv bolus muju
Two compartment model iv bolus muju
 
Absorption of drugs from non per os extravascular administration
Absorption of drugs from non per os extravascular administrationAbsorption of drugs from non per os extravascular administration
Absorption of drugs from non per os extravascular administration
 
MECHANISMS OF DRUG ABSORPTION
MECHANISMS OF DRUG  ABSORPTIONMECHANISMS OF DRUG  ABSORPTION
MECHANISMS OF DRUG ABSORPTION
 
Distribution of drugs
Distribution of drugsDistribution of drugs
Distribution of drugs
 
Drug distribution
Drug distributionDrug distribution
Drug distribution
 
Non linear pharmacokinetics and different volumes of distribution
Non linear pharmacokinetics and different volumes of distributionNon linear pharmacokinetics and different volumes of distribution
Non linear pharmacokinetics and different volumes of distribution
 
Theories of Dissolution
Theories of DissolutionTheories of Dissolution
Theories of Dissolution
 

Similar to Pharmacokinetic parameters

CO1_L10_ Introduction to Pharmacology and Therapeutics Part 3.pptx
CO1_L10_ Introduction to Pharmacology and Therapeutics  Part 3.pptxCO1_L10_ Introduction to Pharmacology and Therapeutics  Part 3.pptx
CO1_L10_ Introduction to Pharmacology and Therapeutics Part 3.pptx
Samwel Samwel
 
Clinical pharmacokinetics
Clinical pharmacokineticsClinical pharmacokinetics
Clinical pharmacokinetics
Dr. Manu Kumar Shetty
 
lecture 4 Clinical pharmacokinetics.pptx
lecture 4 Clinical pharmacokinetics.pptxlecture 4 Clinical pharmacokinetics.pptx
lecture 4 Clinical pharmacokinetics.pptx
WaqasAhmad535
 
Clinical pharmacokinetics & pharmacodynamics 1
Clinical pharmacokinetics & pharmacodynamics 1Clinical pharmacokinetics & pharmacodynamics 1
Clinical pharmacokinetics & pharmacodynamics 1
BhushanSurana2
 
Multiple Dosage regimen
Multiple Dosage regimenMultiple Dosage regimen
Multiple Dosage regimen
Md. Mohabbot Hossen
 
Pharmacokinetics
PharmacokineticsPharmacokinetics
Pharmacokinetics
Usha Prakash
 
Health informathics part passive reabsorption2.pptx
Health informathics part passive reabsorption2.pptxHealth informathics part passive reabsorption2.pptx
Health informathics part passive reabsorption2.pptx
MelakeselamGedamu
 
1612188029641020.pptx
1612188029641020.pptx1612188029641020.pptx
1612188029641020.pptx
MuhannadOmer
 
Drug distribution and its clinical significance
Drug distribution and its clinical significanceDrug distribution and its clinical significance
Drug distribution and its clinical significance
DeepakPandey379
 
Therapeutic drug monitoring LECTURE 2.pptx pharmaceutical sciences
Therapeutic drug monitoring LECTURE 2.pptx pharmaceutical sciencesTherapeutic drug monitoring LECTURE 2.pptx pharmaceutical sciences
Therapeutic drug monitoring LECTURE 2.pptx pharmaceutical sciences
khalafpharm
 
basicprinciplesofpharmacology-180511150709.pdf
basicprinciplesofpharmacology-180511150709.pdfbasicprinciplesofpharmacology-180511150709.pdf
basicprinciplesofpharmacology-180511150709.pdf
jayantigupta9
 
Basic principles of pharmacology
Basic principles of pharmacologyBasic principles of pharmacology
Basic principles of pharmacology
Richa Kumar
 
quantitative pharmacokinetics material.pptx
quantitative pharmacokinetics material.pptxquantitative pharmacokinetics material.pptx
quantitative pharmacokinetics material.pptx
bryanosas2000
 
PHARMACOKINETICS BScN.pptx
PHARMACOKINETICS BScN.pptxPHARMACOKINETICS BScN.pptx
PHARMACOKINETICS BScN.pptx
MuhammadAbbasWali
 
Therapeutic Drugs Monitoring
Therapeutic Drugs Monitoring Therapeutic Drugs Monitoring
Therapeutic Drugs Monitoring
wadalshigil84
 
PK- Basic terminologies.pptx
PK- Basic terminologies.pptxPK- Basic terminologies.pptx
PK- Basic terminologies.pptx
Dr. Nipa Mendapara
 
Therapeutic drug monitoring
Therapeutic  drug monitoringTherapeutic  drug monitoring
Therapeutic drug monitoring
Ramakanth Gadepalli
 
Area under the curve- Dr ASHWIN R
Area under the curve- Dr ASHWIN RArea under the curve- Dr ASHWIN R
Area under the curve- Dr ASHWIN R
ashwin ravi
 
iv infusions.pptx
iv infusions.pptxiv infusions.pptx
iv infusions.pptx
MuhammadAhmadPharmD
 

Similar to Pharmacokinetic parameters (20)

CO1_L10_ Introduction to Pharmacology and Therapeutics Part 3.pptx
CO1_L10_ Introduction to Pharmacology and Therapeutics  Part 3.pptxCO1_L10_ Introduction to Pharmacology and Therapeutics  Part 3.pptx
CO1_L10_ Introduction to Pharmacology and Therapeutics Part 3.pptx
 
Clinical pharmacokinetics
Clinical pharmacokineticsClinical pharmacokinetics
Clinical pharmacokinetics
 
lecture 4 Clinical pharmacokinetics.pptx
lecture 4 Clinical pharmacokinetics.pptxlecture 4 Clinical pharmacokinetics.pptx
lecture 4 Clinical pharmacokinetics.pptx
 
Clinical pharmacokinetics & pharmacodynamics 1
Clinical pharmacokinetics & pharmacodynamics 1Clinical pharmacokinetics & pharmacodynamics 1
Clinical pharmacokinetics & pharmacodynamics 1
 
Multiple Dosage regimen
Multiple Dosage regimenMultiple Dosage regimen
Multiple Dosage regimen
 
Pharmacokinetics
PharmacokineticsPharmacokinetics
Pharmacokinetics
 
Bioavailability ppt
Bioavailability pptBioavailability ppt
Bioavailability ppt
 
Health informathics part passive reabsorption2.pptx
Health informathics part passive reabsorption2.pptxHealth informathics part passive reabsorption2.pptx
Health informathics part passive reabsorption2.pptx
 
1612188029641020.pptx
1612188029641020.pptx1612188029641020.pptx
1612188029641020.pptx
 
Drug distribution and its clinical significance
Drug distribution and its clinical significanceDrug distribution and its clinical significance
Drug distribution and its clinical significance
 
Therapeutic drug monitoring LECTURE 2.pptx pharmaceutical sciences
Therapeutic drug monitoring LECTURE 2.pptx pharmaceutical sciencesTherapeutic drug monitoring LECTURE 2.pptx pharmaceutical sciences
Therapeutic drug monitoring LECTURE 2.pptx pharmaceutical sciences
 
basicprinciplesofpharmacology-180511150709.pdf
basicprinciplesofpharmacology-180511150709.pdfbasicprinciplesofpharmacology-180511150709.pdf
basicprinciplesofpharmacology-180511150709.pdf
 
Basic principles of pharmacology
Basic principles of pharmacologyBasic principles of pharmacology
Basic principles of pharmacology
 
quantitative pharmacokinetics material.pptx
quantitative pharmacokinetics material.pptxquantitative pharmacokinetics material.pptx
quantitative pharmacokinetics material.pptx
 
PHARMACOKINETICS BScN.pptx
PHARMACOKINETICS BScN.pptxPHARMACOKINETICS BScN.pptx
PHARMACOKINETICS BScN.pptx
 
Therapeutic Drugs Monitoring
Therapeutic Drugs Monitoring Therapeutic Drugs Monitoring
Therapeutic Drugs Monitoring
 
PK- Basic terminologies.pptx
PK- Basic terminologies.pptxPK- Basic terminologies.pptx
PK- Basic terminologies.pptx
 
Therapeutic drug monitoring
Therapeutic  drug monitoringTherapeutic  drug monitoring
Therapeutic drug monitoring
 
Area under the curve- Dr ASHWIN R
Area under the curve- Dr ASHWIN RArea under the curve- Dr ASHWIN R
Area under the curve- Dr ASHWIN R
 
iv infusions.pptx
iv infusions.pptxiv infusions.pptx
iv infusions.pptx
 

Recently uploaded

Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
bkling
 
Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
pal078100
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
Dr. Rabia Inam Gandapore
 
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIONDACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
DR SETH JOTHAM
 
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdfBENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
DR SETH JOTHAM
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Dr Jeenal Mistry
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Prof. Marcus Renato de Carvalho
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
MedicoseAcademics
 
263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,
sisternakatoto
 
Knee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdfKnee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdf
vimalpl1234
 
Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...
Sujoy Dasgupta
 
New Drug Discovery and Development .....
New Drug Discovery and Development .....New Drug Discovery and Development .....
New Drug Discovery and Development .....
NEHA GUPTA
 
24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all
DrSathishMS1
 
NVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control programNVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control program
Sapna Thakur
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
Dr. Vinay Pareek
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
NephroTube - Dr.Gawad
 
heat stroke and heat exhaustion in children
heat stroke and heat exhaustion in childrenheat stroke and heat exhaustion in children
heat stroke and heat exhaustion in children
SumeraAhmad5
 
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #GirlsFor Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
Savita Shen $i11
 
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptxMaxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
د.محمود نجيب
 

Recently uploaded (20)

Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
 
Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
 
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIONDACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
 
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdfBENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
 
263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,
 
Knee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdfKnee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdf
 
Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...
 
New Drug Discovery and Development .....
New Drug Discovery and Development .....New Drug Discovery and Development .....
New Drug Discovery and Development .....
 
24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all
 
NVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control programNVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control program
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
 
heat stroke and heat exhaustion in children
heat stroke and heat exhaustion in childrenheat stroke and heat exhaustion in children
heat stroke and heat exhaustion in children
 
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #GirlsFor Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
 
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptxMaxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
 

Pharmacokinetic parameters

  • 2. Outline • Enumeration and brief overview of different pharmacokinetic parameters- • Absorption- • Bioavailability • Distribution- • Volume of distribution • Metabolism and Excretion- • Clearance • Half life and order of elimination • Elimination constant • Dosing regimens • Therapeutic drug monitoring
  • 3. Concentration time graph • Peak plasma concentration • Time of peak plasma concentration • Area under the curve • Minimum effective concentration • Maximum safe concentration • Onset of action • Time of onset • Duration of action • Intensity of action • Therapeutic range • Therapeutic index Maximum
  • 4. Bioavailability (F) • Fraction of administered drug which reaches systemic circulation in unchanged form • It is expressed as fraction or percentage and can range between 0 and 1 • In a concentration time graph, the area under curve (AUC) represents the total dose of drug in plasma • Thus, bioavailability can be calculated as-
  • 5. Bioavailability • Factors affecting bioavailability of a drug include- • Particle size • Degree of ionization and pH at the site of absorption • Gastric emptying & GI motility (TCA and anti histamines) • Food and other substances (Grapefruit juice and felodipine) • First pass metabolism (Sublingual vs Oral) • Drug interactions (Tetracyclines forming complexes with iron and antacids in gut lumen, bisphosphonates with calcium) • Route of administration • Area and perfusion of site of drug administration (Muscle vs Fat)
  • 6. Distribution of drug • One compartment model- • Few drugs (Aminoglycosides) are rapidly distributed in tissues and aren’t significantly accumulated in tissues such that the entire body works like a single compartment. • Their plasma concentration will decrease mostly due to clearance or metabolism and thus they will show continuous logarithmic decline in concentration time graph.
  • 7. Distribution of drug • Two compartment model- • Few drugs are slowly absorbed into peripheral tissues like Vancomycin and Digoxin. • Their plasma concentration graph will show two slopes of decline which are of redistribution and elimination.
  • 8. Distribution of drug • Factors determining rate of distribution and amount of drug distributed to different body tissues- • Regional blood flow to the tissue • Capillary permeability • Volume of tissue and tissue selectivity of drug (Incorporation of Bisphosphonates into bone) • Extent of plasma protein binding of drug as only the unbound fraction is available for transport into tissues • Presence of barriers (Blood brain barrier)
  • 9. Volume of distribution (Vd) • It is an apparent volume available for administered amount of drug to disperse considering the whole human body as a homogenous solution • Volume of distribution = Quantity of drug administered/ Plasma concentration (C) • It shows the extent of redistribution or accumulation of drug in tissues • Eg- Warfarin has low (Vd) owing to its high plasma protein binding while Chloroquine has high (Vd) because of its accumulation into peripheral fat.
  • 10. Volume of distribution • It is used to determine the loading dose of a drug • Loading dose = Target concentration X Volume of distribution Suppose the target concentration of a drug is 15mg/ml and Volume of distribution of the same drug is 30 L. • Since, the Volume of distribution of a drug in a patient doesn’t depend on the amount of drug administered or the route of administration, it will remain same Then, the loading dose will be 15mg/ml X 30L = 1.5g/L X 30L i.e, 45 g
  • 11. Volume of distribution • Factors affecting volume of distribution • Lipid solubility of the drug • Ionization of the drug at physiological pH • Plasma protein binding of the drug • Limitation- It is assumed that the concentration of drug in different tissues corresponds to the plasma concentration and that the response of drug varies in accordance with the plasma concentration which may not be true in each case.
  • 12. Kinetics of drug elimination • First order kinetics (A) - The rate of drug elimination varies proportionately to the plasma concentration of drug. Most of the drugs follow this pattern of elimination. • Here, as plasma concentration of drug decrease, the rate of drug elimination decreases and vice versa. (Rate of drug elimination is the amount of drug removed from blood per unit time)
  • 13. Kinetics of drug elimination • Saturation kinetics (B) - The rate of drug elimination becomes constant after a certain level of plasma concentration is reached i.e., A fixed amount of drug will be removed from blood in unit time. The drugs include Phenytoin, Ethanol, Salicylates • For few drugs(C), (Valproate and Disopyramide), as the plasma concentration increases, the plasma protein gets saturated and the concentration of unbound drug increases leading to disproportionately increased elimination of drug
  • 14. Clearance • Volume of plasma that contains the amount of drug that is removed from body per unit time • Suppose, the rate of elimination of drug is 10mg/min and plasma concentration of drug is 5mg/ml. Then, Clearance = 10 mg/min/5mg/ml = 2ml/min i.e, 2ml of plasma is cleared of drug every minute • It remains constant for drugs showing first order metabolism • The clearance of a drug include- • Hepatic clearance • Renal clearance • Others
  • 15. Clearance • Factors affecting clearance of a drug include- • Extraction ratio of organ (liver, kidney)- The fraction of drug removed from plasma flowing through the organ per unit of time. i.e., If a drug X has a concentration of 15mg/ml in portal vein (CA) and concentration of 10mg/ml in hepatic vein (CV). Then, hepatic extraction ratio will be- CA - CV/ CA = 5/15 = 1/3 • Plasma protein binding of drug • Blood flow to the organ (liver, kidney) • Functional state of kidney, liver • Interactions with other drugs (enzyme inducers/inhibitors)
  • 16. Steady-state concentration • When the drug is administered at a constant rate or at regular intervals, the cumulative accumulation of drug and simultaneous elimination are balanced and a steady concentration is reached • For maintenance of steady state concentration, the vol of drug that is cleared of drug must be replenished continuously. Thus, clearance is used for calculating maintenance dose as under- where, Cp is the plasma concentration of drug, CL is clearance and F is bioavailability of drug
  • 17. Elimination rate constant (Ke) • Fraction of drug that is excreted from the body per unit time • Rate of elimination = Ke X Concentration of drug in plasma • Thus, Ke = Clearance/Volume of distribution • The relationship between concentration at a time t (C) after administering the drug and the steady state concentration (Css) of the drug is derived as- • Thus, we can calculate plasma concentration at a time t by knowing the elimination rate constant and steady state concentration of the drug
  • 18. Half life (t1/2) • Half life of a drug is the time taken for its plasma concentration to drop to half of the peak plasma concentration • Half life of a drug determines • Duration of action of drug after a single dose • Time required to reach steady state concentration • Dosing frequency • For a drug following first order kinetics, the half life can be derived as- i.e, the half life depends on both volume of distribution and clearance of the drug
  • 19. Dosage regimens • Ideal dosage regimen- Dosing intervals and amount of drug given in each dose is such that the plasma concentration of drug stays above the minimum effective concentration within the therapeutic window • The dosage regimen for different drugs is arrived through different ways- • For drugs where physical parameters can be assessed (BP, Blood glucose), a trial and error method is used where the dose and intervals are titrated accordingly • Few drugs have wide range of therapeutic window (Penicillins) where maximum efficacy is desired • The change in plasma concentration (ΔC) after a single oral dose- • Thus, the loading dose becomes- • For maintenance dose- (where T is the dosing interval)
  • 20. Therapeutic drug monitoring • Purpose- To adjust plasma concentration and maintain it within a specified range. • Measurement of both values of minimum and maximum concentrations are to be recorded. • The necessary dose adjustment is done considering the clearance of drug to remain constant. • Applied when- • The drug has a low therapeutic index • There is a good plasma concentration- biological response relationship • There are no other easily measurable physiological parameters • Or, to monitor adherence or adverse drug reactions
  • 21. Therapeutic drug monitoring • Sampling of blood is to be done only after steady state of plasma concentration is reached, ie, after five half lives except in case of toxicity • After the steady state is reached, sampling to be done after proper time for distribution of drug to finish. • A therapeutic range of plasma concentration is used to guide the desired concentration of drug